PANAGENE is specialized in manufacturing PNA and PNA based molecular diagnostic reagents. Recently PANAGNE commercialized
PANAMutyper™ R Series for liquid biopsy specimens. PANAMutyper™ R Series provides the best solution to cancer diagnostics based on
Real-time PCR platform. Taking advantages from PNAClamping and melting peak analysis technologies, PANAMutyper™ R Series provides
multiplex genotyping information in high sensitivity and specificity. PANAMutyper™ R Series guarantees 0.1% of LOD so can detect
mutation in high wild type background. PANAMutyper™ R series makes you easy to diagnose and monitor the patients in short time in
your site directly. PANAMutyper™ R Series has EGFR, KRAS, NRAS, they got CE-IVD mark. As a leading molecular diagnostic technology
provider, PANAGENE keeps expand MDx product categories from cancer to infectious disease.